Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities.
about
Evaluation of regional antibiograms to monitor antimicrobial resistance in Hampton Roads, VirginiaGenodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units.Antimicrobial stewardship programs in health care systems.Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries.Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureusDifferential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosaThe use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics?Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.Defining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient.Treatment of Pseudomonas aeruginosa infection in critically ill patients.Epidemiological interpretation of studies examining the effect of antibiotic usage on resistanceAntimicrobial resistance in hospitals: how concerned should we be?Diversity of antimicrobial use and resistance in 42 hospitals in the United States.Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia.Emerging trends in antibiotic use in US hospitals: quality, quantification and stewardship.Application of antimicrobial stewardship to optimise management of community acquired pneumonia.Emergence and spread of antibiotic resistance following exposure to antibiotics.Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study.Fluoroquinolone use and fluoroquinolone-resistant Pseudomonas aeruginosa is declining in US academic medical centre hospitals.Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States.Challenges in measuring antibiotic consumption.Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals.Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy.The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists.Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.Determination and health risk assessment of enrofloxacin, flumequine and sulfamethoxazole in imported Pangasius catfish products in Thailand.Seasonality and temporal correlation between community antibiotic use and resistance in the United States.Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients.Risk factors associated with resistance to ciprofloxacin in clinical bacterial isolates from intensive care unit patients.The impact of antibiotic use on transmission of resistant bacteria in hospitals: Insights from an agent-based model.
P2860
Q28649661-B03D4DD5-ECCB-4251-85DD-A666CB8A1360Q33319504-0E24D080-0C2A-40E1-B4B2-E56360D9B4FAQ34097674-5D0BE3AD-414B-4637-BC5B-63430AEFB208Q34609380-933FF2E6-703C-4087-9D9D-017AFCAE2548Q34680578-173C1D21-B401-472E-A3E3-564DF9E86E65Q34680681-22AD186F-A1C4-4F5D-9533-5D9A74A3AFDEQ35558420-68AFF8A9-6FE2-4E13-BDB2-5C2E6F416FC9Q35873418-DFCBA008-425B-4EC0-8FB1-A7AAFA7B7442Q36161246-430F0425-4BF8-4A54-BCA3-9388ED4A2AF9Q36607415-47C97BD7-312A-48B5-B26E-53332161AE70Q36757737-BB360AAE-2659-49AD-88F0-3B375E50B4D0Q37088893-11B1ADED-1C38-4B05-8D2B-FBC945ED7359Q37199197-974D807E-274D-48E3-8B54-E997121236E7Q37532114-CB22161A-684F-496D-8153-C32DD6CC0343Q37778826-869BCBC8-BEC0-456A-A72A-7FFFCBF132C4Q37890027-B8A9D395-0C36-4013-AB1E-889CF92A17DEQ37896674-E04C2FE6-3C6B-425B-98F1-79B60F9395FFQ40172700-DC8AF5C4-ACC1-4F3F-8A0C-97D5F8261467Q42272970-CCA1B453-C60D-4203-8871-1A2C3454C96CQ43169894-ADA7BC12-0041-40EA-BAD7-8505BDD573F5Q44035214-919E10C2-DE81-447B-BA9A-6823716E4D71Q44578742-AF828ADC-8991-46BF-A8DC-41E54FFA8590Q44912219-AB576F83-3F31-49F1-9435-23E7FE1AF135Q44926822-3BD47823-0CC5-4842-BE16-171713EC97E5Q44931814-7B0F22AC-7A00-4CCF-9789-650B5401E7A2Q45280485-DD1DFA19-9E51-4C4E-9B42-A048834B29AAQ46510293-2DCE3F33-162D-455A-8372-065B506256C6Q46906475-8EC4D61A-3119-4628-966E-CF2BC2D8F1B0Q47316380-17D47228-44A7-4753-8FC4-BB331897D0F5Q47427897-1ADEB1AC-CA9F-4B07-9A02-CBF93B98AE56Q48956027-D544F76D-76D4-42C3-BBBF-E8BEEB5C9ED5Q54446069-28E683B1-0506-4F6D-BADF-D19DF3446492Q55097439-19C1B0FC-2DF8-4423-841C-44C57CC72B31
P2860
Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Predicting hospital rates of f ...... their surrounding communities.
@en
Predicting hospital rates of f ...... their surrounding communities.
@nl
type
label
Predicting hospital rates of f ...... their surrounding communities.
@en
Predicting hospital rates of f ...... their surrounding communities.
@nl
prefLabel
Predicting hospital rates of f ...... their surrounding communities.
@en
Predicting hospital rates of f ...... their surrounding communities.
@nl
P2093
P2860
P356
P1476
Predicting hospital rates of f ...... their surrounding communities.
@en
P2093
Christopher K Johnson
Donna McClish
Richard P Wenzel
Ronald E Polk
P2860
P304
P356
10.1086/422647
P407
P577
2004-08-02T00:00:00Z